TheraRadar
Data updated: May 26, 2026

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (cefepime hydrochloride)

Infectious Disease Approved 2010-05-06

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is indicated for the treatment of Pneumonia; Febrile Neutropenia; Urinary Tract Infection; Skin and Skin Structure Infections; Intra-Abdominal Infections.

Source: FDA Label • B BRAUN

How CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Works

Cefepime is a fourth-generation cephalosporin that exerts bactericidal activity by inhibiting bacterial cell wall synthesis. It binds to one or more of the penicillin-binding proteins (PBPs), which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. This disruption leads to bacterial cell wall instability and subsequent osmotic lysis. It possesses a broad spectrum of activity against various Gram-positive and Gram-negative bacteria, including *Pseudomonas aeruginosa* and *Streptococcus pneumoniae*.

1
Indication
--
Phase 3 Trials
16
Years on Market

Details

Status
Prescription
First Approved
2010-05-06
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: CEFEPIME HYDROCHLORIDE

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Approval History

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
12 FDA actions from 2010 to 2026
Apr 2026 SUPPL
Label · Labeling
Mar 2022 SUPPL
Label · Labeling
Nov 2015 SUPPL
Label · Labeling

What CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Treats

5 indications

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is approved for 5 conditions since its original approval in 2010. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pneumonia
  • Febrile Neutropenia
  • Urinary Tract Infection
  • Skin and Skin Structure Infections
  • Intra-Abdominal Infections
Source: FDA Label

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
4 shared
CHARTWELL RX
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
4 shared
SAMSON MEDCL
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
4 shared
Baxter
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT01484015 IRB00015247 NCI-2011-02422, CCCWFU 02110 Ph 1 completed Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER FDA Label Details

Indications & Usage

FDA Label (PDF)

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is indicated for the treatment of Pneumonia; Febrile Neutropenia; Urinary Tract Infection; Skin and Skin Structure Infections; Intra-Abdominal Infections.

Track CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.